PARCKA PARLEYS is a monthly, one hour, seminar series focusing on various topics around addiction, held the 3rd Tuesday of each month. A light lunch is provided to attendees. There are over 200 potential attendees on the list serve that receive the announcements each month consisting of staff, faculty, and community members. In October 2019, continuous medical education (CME) credits started being offered and the Parleys are virtually broadcast to attendees across the nation. PARCKA Parley’s are archived on the PARCKA website.
UPCOMING PARCKA PARLEYS:
|December 15, 2020||
Cost-effectiveness of Extended-release Injectable Naltrexone Among Incarcerated Persons Pre-reentry
Ali Jalali, PhD
Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV and HIV, Well Cornell Medical College
Strategies for the treatment of opioid use disorder (OUD) in criminal justice settings have garnered increasing attention given the high prevalence of OUD among justice-involved populations, and the elevated risk of overdose mortality shortly after release from incarceration. Extended-release naltrexone, an opioid antagonist, is an evidence-based pharmacotherapy that prevents opioid relapse and overdose for approximately 30 days. This talk will present results from a comprehensive economic evaluation conducted alongside a clinical trial testing the effectiveness of extended-release naltrexone administered to incarcerated persons with OUD, just prior to reentry, vs. referral to community-based treatment
|January 19, 2021||
Health Inequities and Tobacco Cessation: Population-Level Scale Up
David Wetter, PhD, MS
University of Utah, Center for Health Outcomes and Population Equity (HOPE)
Over the last several decades, tobacco use has become increasingly concentrated among individuals with low education, living in poverty, and the uninsured and unemployed; and tobacco plays a critical role in health inequities, accounting for an astounding 58% of the socioeconomic status (SES) gradient in mortality among U.S. men. Moreover, low SES tobacco users have greater difficulty quitting, at least in part because of less awareness, access, and use of evidence-based cessation treatments. This presentation describes a line of research designed to scale up patient engagement in evidence-based cessation treatment in partnership with safety-net healthcare systems.
PREVIOUS PARLEYS - 2020:
|Nov. 17, 2020||
Had to cancel and is rescheduled for Jan. 2021
|October 20, 2020||
Buprenorphine Use in the Inpatient and Peri-operative Hospital Setting
Michael Moss, MD
University of Utah Posion Control Center
Patients with opioid use disorder often require hospitalization for medical and surgical complications from IV drug use. Enduring opioid withdrawal while hospitalized is a major challenge for these patients. This talk will explore buprenorphine as a tool in managing pain and withdrawal in the inpatient and peri-operative setting.
|September 15, 2020||
Human Trafficking: warning signs, awareness, addiction
Discussion of local trafficking, crisis outreach responses, awareness and signs of trafficking, exploitation of women, substance use involvement, and resources for help.
|Aug. 18, 2020||
Opioid Induced Respiratory Failure (OIRD). Are there early warning signs?
Robert Farney, MD, FACCP
University of Utah, Pulmonology & Sleep Medicine
The discussion will be on how opioids suppress all aspects of respiration, including drive and rhythm. Respiratory effects occur mainly during sleep or non-awake states. Dr. Farney will also address the fact that there is a sub-population with enhanced sensitivity and without known risk factors, and will review the background and manifestations of opioid toxicity that occur during sleep.
Pdf of slides (There were technical difficulties and we were not able to record this presentation. If you would like the PPT version of the slides please contact PARCKA)
|July 21, 2020||
“Veterans’ Experiences with Primary Care-Based Opioid Replacement Therapy”
Susan Zickmund, PhD
University of Utah, Division of Epidemiology
|June 16, 2020||
|May 19, 2020||
“Training Providers and Staff about Chronic Pain Management and Opioids in Long-Term Care”
Linda Edelman, PhD RN
University of Utah College of Nursing
|April 21, 2020||
April 2020 PARCKA PARLEYS was canceled due to COVID-19 related precautions. We are working to reschedule this PARLEYS for later in 2020.
|March 17, 2020||
March 2020 PARCKA PARLEYS was canceled due to COVID-19 related precautions. We are working to reschedule this PARLEYS for later in 2020.
|February 18, 2020||
"Family Perspectives in the Substance Use Disorder Crisis”
Dennis Cecchini, Ciara Gregovich, and Joyce Kim
|January 21, 2020||
“Opioids and the Science of Addiction: A Science-Based Approach to Classroom Opioid Education”
Genetic Science Learning Center, University of Utah
PREVIOUS PARLEYS - 2019:
|January 15, 2019||
"Addiction Care at the University of Utah Neuropsychiatric Institute"
Elizabeth F. Howell, MD, MS, DLFAPA, DFADAM
University Neuropsychiatric Institute
|February 19, 2019||
"Siri, Rate my Counselor: Scaling Up the Evaluation of Substance Use Counseling with Speech Signal Processing and Machine Learning"
Zac Imel, PhD
Jake Van Epps, PhD
Educational Psychology, University of Utah
|March 19, 2019||
"Marijuana in Pregnancy: Sorting Through Hazy Evidence"
Torri Metz, MD, MS
Obstetrics & Gynecology, University of Utah
|April 16, 2019||
"SBIRT and the Next Sphygmomanometer in Utah: Understanding SBIRT Education at the University of Utah and Utah"
Melissa Cheng, MD, MOH, MHS
Rocky Mountain Center for Occupational and Environmental Health, University of Utah
|May 21, 2019||
"Project ECHO - We may not be Amazon, but we are breaking down the walls between specialty and primary care"
Paula Cook, MD
University Neuropsychiatric Institute
Christina Choate, Lead Program Coordinator
Project ECHO, University of Utah
|June 18, 2019||
"Stigma is Recovery's Biggest Enemy"
Utah Department of Health Syringe Exchange Program
|July 16, 2019||
"Amidst Tragedy, A Frameshift: Evolving Policy Initiatives to Address Prescription Opioid Recipients"
Stefan Kertesz, MD, MSc
|September 17, 2019||
"Let's Talk to the Experts - Advanced Treatment Options for Opioid Use"
Katherine L. Carlson, MD, FASAM, Medical Director, Project Reality
Christina Zidow, LCSW, Chief Operating Officer, Odyssey House
Misty McIntyre Goodsell, LCSW, Director of Research & Development, Odyssey House
|October 15, 2019||
"Misfits between the Law and People with Opioid Use Disorders"
Leslie Francis, JD, PhD
Teneille Brown, JD
S.J. Quinney College of Law, University of Utah
|November 15, 2019||
"Marijuana and the New Utah Law"
Steve Ipsen, MSN, RN, Director of Clinical Services
Utah Department of Health
|December 17, 2019||
"Preventing Adolescent Vaping: What We Know and What We Don't"
Jason Burrow-Sanchez, PhD & Benjamin Ratcliff, BS
Department of Educational Psychology, University of Utah
PREVIOUS PARLEYS - 2018:
|October 16, 2018||
"Challenges of Addiction in the Community - Myths & Realities"
Bill Cosgrove, MD, Salt Lake County Health Board
Tayler Nelson, Overdose Prevention Health Educator, Salt Lake County Health Department
Adam Gordon, MD, MPH, Director, PARCKA
|November 20, 2018||"Utah Support Advocates for Recovery Awareness (USARA)"|